Value-based price for access (VBPA) may increase access of specialty drugs for patients.
Keith Bratti
Advertisement
Head of access & BDL strategy, Novartis Pharmaceuticals Corporation
Articles by Keith Bratti
Advertisement
Latest Updated Articles
Advertisement
Advertisement